Hirequest Inc

Hirequest Inc (HQI) Stock Analysis

$17.730

+1.082 (+6.10%)At close

Loading chart…
High
18.630
Open
16.940
VWAP
17.73
Volume
58.97K
Mkt Cap
172.20M
Low
16.820
Amount
1.05M
EV/EBITDA, TTM
13.98

HireQuest, Inc. is a franchisor of direct dispatch, executive search, and commercial staffing solutions for HireQuest Direct, HireQuest Health, MRINetwork, Snelling, and TradeCorp across the United States and international markets. The Company provides staffing solutions across industries, including construction, light industrial, healthcare, finance, manufacturing, cybersecurity, and engineering. HireQuest Direct focuses on daily work/daily pay jobs primarily for construction and light industrial customers. TradeCorp focuses on short-term skilled construction jobs. HireQuest Health specializes in skilled personnel in the healthcare and dental industries. Snelling and HireQuest focus on longer-term staffing positions in the light industrial and administrative arenas. Northbound, MRI, SearchPath, and Sales Consultants focus on executive, managerial, and professional recruitment services, although they also offer short-term consultant services.

AI analysis of Hirequest Inc (HQI)

Hold

HireQuest Inc (HQI) is currently a hold. The stock's current price is $16.45, which is below the analyst price target of $19, indicating potential upside. However, the RSI is at 39.83, suggesting the stock is nearing oversold territory, which could lead to further downward pressure in the short term. Additionally, the stock has experienced a 4.25% decline over the past five days and a 13.74% decline over the past 20 days, indicating negative momentum. The main risk is the recent rejection of a $105 million acquisition offer, which may impact investor sentiment.

Valuation Metrics

The current forward P/E ratio for Hirequest Inc (HQI) is 18.42, compared to its 5-year average forward P/E of 22.02.

Forward P/E

Fair
5Y Average P/E
22.02
Current P/E
18.42
Overvalued
32.37
Undervalued
11.66

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
12.70
Current EV/EBITDA
13.98
Overvalued
16.73
Undervalued
8.66

Forward P/S

Fair
5Y Average P/S
5.95
Current P/S
7.14
Overvalued
7.45
Undervalued
4.44

Alphio AI Price Scenarios for HQI

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%HQI

$8.97

Scenario price

B

Base

Base · 50%HQI

$8.11

Scenario price

B

Bear

Bear · 25%HQI

$8.02

Scenario price

Events Timeline

2026-08-10 (ET)

17:00:00

HireQuest Reports Q2 Revenue of $8.1M

17:00:00

HireQuest Reports Q2 Revenue of $8.1M

2026-05-27 (ET)

08:10:00

TrueBlue Rejects HireQuest's $105 Million Acquisition Proposal

2026-05-12 (ET)

16:20:00

HireQuest Reports Q1 Revenue of $6.5M, Down Year-over-Year

2026-03-30 (ET)

16:10:00

HireQuest Reports Q4 Revenue of $7M

News

HQI FAQ — answered by Alphio AI

HireQuest, Inc. is a franchisor of direct dispatch, executive search, and commercial staffing solutions for HireQuest Direct, HireQuest Health, MRINetwork, Snelling, and TradeCorp across the United States and international markets. The Company provides staffing solutions across industries, including construction, light industrial, healthcare, finance, manufacturing, cybersecurity, and engineering. HireQuest Direct focuses on daily work/daily pay jobs primarily for construction and light industrial customers. TradeCorp focuses on short-term skilled construction jobs. HireQuest Health specializes in skilled personnel in the healthcare and dental industries. Snelling and HireQuest focus on longer-term staffing positions in the light industrial and administrative arenas. Northbound, MRI, SearchPath, and Sales Consultants focus on executive, managerial, and professional recruitment services, although they also offer short-term consultant services. It operates in the Industrials sector (SERVICES-HELP SUPPLY SERVICES industry).

HireQuest Inc (HQI) is currently a hold. The stock's current price is $16.45, which is below the analyst price target of $19, indicating potential upside. However, the RSI is at 39.83, suggesting the stock is nearing oversold territory, which could lead to further downward pressure in the short term. Additionally, the stock has experienced a 4.25% decline over the past five days and a 13.74% decline over the past 20 days, indicating negative momentum. The main risk is the recent rejection of a $105 million acquisition offer, which may impact investor sentiment.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

Related articles

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading